TRACON Pharmaceuticals, Inc. (TCON)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 12.04 Million | - | 346 Thousand | - | - | 3 Million |
| Cost of Revenue | 12.27 Million | 16 Thousand | 14 Thousand | 12 Thousand | 22 Thousand | 30.46 Million |
| Gross Profit | -232 Thousand | -16 Thousand | 332 Thousand | -12 Thousand | -22 Thousand | -27.46 Million |
| Operating Expenses | 18.92 Million | 27.89 Million | 28.69 Million | 16.22 Million | 22.29 Million | 37.74 Million |
| Selling, General and Administrative Expenses | 6.66 Million | 14 Million | 17.54 Million | 8.02 Million | 7.76 Million | 7.28 Million |
| Research and Development Expenses | 12.27 Million | 13.88 Million | 11.14 Million | 8.19 Million | 14.53 Million | 30.46 Million |
| Other Expenses | - | -1.24 Million | -320 Thousand | -7000.00 | -378 Thousand | 12 Thousand |
| Cost and Expenses | 18.94 Million | 27.89 Million | 28.69 Million | 16.22 Million | 22.29 Million | 37.74 Million |
| Operating Income | -6.89 Million | -27.89 Million | -28.34 Million | -16.22 Million | -22.29 Million | -34.74 Million |
| Interest Expense | 7.3 Million | 994 Thousand | 318 Thousand | 545 Thousand | 386 Thousand | 231 Thousand |
| Income Tax Expense | - | 177 Thousand | 59 Thousand | 551 Thousand | -16 Thousand | 12 Thousand |
| Earnings before Tax | -3.58 Million | -29.13 Million | -28.66 Million | -16.77 Million | -22.67 Million | -34.95 Million |
| Net Income | -3.58 Million | -29.31 Million | -28.72 Million | -17.32 Million | -22.65 Million | -34.95 Million |
| Earnings Per Share Basic | -2.20 | -28.02 | -33.30 | -38.63 | -149.35 | -259.47 |
| Earnings Per Share Diluted | -2.19 | -28.02 | -33.30 | -38.57 | -149.35 | -259.47 |
| Weighted Average Shares Outstanding | 1.63 Million | 1.04 Million | 862.63 Thousand | 448.52 Thousand | 151.71 Thousand | 134.73 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.63 Million | 1.04 Million | 862.63 Thousand | 449.2 Thousand | 151.71 Thousand | 134.73 Thousand |
| Gross Margin | -0.02 | - | 0.96 | - | - | -9.15 |
| EBIT Margin | -0.57 | - | -81.93 | - | - | -11.58 |
| Profit Margin | -0.30 | - | -83.02 | - | - | -11.65 |
| EBITDA | -6.88 Million | -27.89 Million | -28.33 Million | -16.22 Million | -22.27 Million | -34.71 Million |
| Earnings Before Tax Margin | -0.57 | - | -81.93 | - | - | -11.58 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 55 Thousand | 100 Thousand | 3.04 Million | 12.04 Million | - | 9 Million |
| Cost of Revenue | - | 4000.00 | 3000.00 | 14 Thousand | 4000.00 | 3000.00 |
| Gross Profit | 55 Thousand | 96 Thousand | 3.04 Million | 12.03 Million | -4000.00 | 8.99 Million |
| Operating Expenses | 2.96 Million | 3.3 Million | 2.63 Million | 18.92 Million | 3.58 Million | 9.77 Million |
| Selling, General and Administrative Expenses | 1.61 Million | 1.43 Million | 1.14 Million | - | 1.26 Million | 1.91 Million |
| Research and Development Expenses | 1.35 Million | 1.87 Million | 1.49 Million | - | 2.32 Million | 3.48 Million |
| Other Expenses | -2000.00 | -9000.00 | -5000.00 | 12.98 Million | 12.99 Million | -5.5 Million |
| Cost and Expenses | 2.96 Million | 3.31 Million | 2.63 Million | 18.94 Million | 3.58 Million | 9.77 Million |
| Operating Income | -2.91 Million | -3.21 Million | 407 Thousand | -6.89 Million | -1.58 Million | -779 Thousand |
| Interest Expense | 75 Thousand | 53 Thousand | -37 Thousand | 7.3 Million | -646 Thousand | -5.5 Million |
| Income Tax Expense | -4000.00 | -39.27 Thousand | -2.36 Million | -153.89 Thousand | -8000.00 | -8000.00 |
| Earnings before Tax | -2.83 Million | -3.16 Million | 439 Thousand | -3.58 Million | 10.76 Million | -6.28 Million |
| Net Income | -2.83 Million | -3.16 Million | 439 Thousand | -3.58 Million | 10.76 Million | -6.28 Million |
| Earnings Per Share Basic | -0.94 | -1.33 | 0.22 | - | 5.85 | -4.09 |
| Earnings Per Share Diluted | -0.94 | -1.33 | 0.18 | - | 5.80 | -4.09 |
| Weighted Average Shares Outstanding | 3 Million | 2.38 Million | 2.46 Million | 1.63 Million | 1.85 Million | 1.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 3 Million | 2.38 Million | 2.01 Million | 1.63 Million | 1.84 Million | 1.53 Million |
| Gross Margin | 1.00 | 0.96 | 1.00 | 1.00 | - | 1.00 |
| EBIT Margin | -52.95 | -32.08 | 0.13 | - | - | -0.09 |
| Profit Margin | -51.62 | -31.68 | 0.14 | -0.30 | - | -0.70 |
| EBITDA | -2.91 Million | -3.2 Million | 410 Thousand | - | -1.58 Million | -779 Thousand |
| Earnings Before Tax Margin | -52.95 | -32.12 | 0.13 | -0.57 | - | -0.09 |
9246
ASGLF
1912
BACHY
9955
ACGLN